Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
11/24/2011 | US20110287536 Simplified method for partial genetic and epigenetic reprogramming of cells |
11/24/2011 | US20110287535 Histone Deacetylase Inhibitors |
11/24/2011 | US20110287534 Automated filling of flexible cryogenic storage bags with therapeutic cells |
11/24/2011 | US20110287533 Novel lowered affinity antibodies and uses therefor |
11/24/2011 | US20110287514 Cytotoxic ribonuclease variants |
11/24/2011 | US20110287512 Compositions for linking zinc finger modules |
11/24/2011 | US20110287484 Expression vector containing the major envelope protein p9 of cystovirus phi6 as a fusion partner, and process for producing a membrane protein using the same |
11/24/2011 | US20110287483 Production of glycoproteins using manganese |
11/24/2011 | US20110287482 Medium for the protein-free and serum-free cultivation of cells |
11/24/2011 | US20110287480 Neurogenin |
11/24/2011 | US20110287470 Cell culture method to form aggregates |
11/24/2011 | US20110287467 Methods of producing recombinant heme-binding proteins and uses thereof |
11/24/2011 | US20110287458 Method and composition for the diagnosis and monitoring of inflammatory diseases |
11/24/2011 | US20110287453 Antibody binding specifically to tdp-43 aggregate |
11/24/2011 | US20110287442 Tumor Antigen Protein, Gene, or Peptides from Topoisimerase 2 Alpha |
11/24/2011 | US20110287429 Use of haploid genomes for genetic diagnosis, modification and multiplication |
11/24/2011 | US20110287406 Novel HCV core+1 protein, methods for diagnosis of HCV infections, prophylaxis, and for screening of anti-HCV agents |
11/24/2011 | US20110287405 Biomass production |
11/24/2011 | US20110287102 Chain extenders |
11/24/2011 | US20110287086 Regeneration of Pancreatic Islets and Reversal of Diabetes by Islet Transcription Factor Genes Delivered in Vivo |
11/24/2011 | US20110287079 Supporting material for cell sheet |
11/24/2011 | US20110287071 Methods of generating tissue using devitalized, acellular scaffold matrices derived from micro-organs |
11/24/2011 | US20110287058 Universal GM-CSF Expressing Bystander Human Cell Line |
11/24/2011 | US20110287056 Agents and methods to elicit anti-tumor immune response |
11/24/2011 | US20110287048 Antigen Specific Tregs and related compositions, methods and systems |
11/24/2011 | US20110287046 Modified streptococcus pneumonia pneumolysin (ply) polypeptides |
11/24/2011 | US20110287043 Melanoma antigens and their use in diagnostic and therapeutic methods |
11/24/2011 | US20110287034 Therapeutic and diagnostic methods relating to cancer stem cells |
11/24/2011 | US20110287032 Novel ctla4-ig immunoadhesins |
11/24/2011 | US20110287029 Inhibition of the beta3 subunit of l-type ca2+ channels |
11/24/2011 | US20110287016 Nucleic acid and corresponding protein entitled 161p2f10b useful in treatment and detection of cancer |
11/24/2011 | US20110287015 Mg53 compositions and methods of use |
11/24/2011 | US20110287014 Antibodies directed against calcium channel subunit alpha2/delta and methods using same |
11/24/2011 | US20110287011 DDR1-Binding Agents and Methods of Use Thereof |
11/24/2011 | US20110287005 Monoclonal antibodies against amyloid beta protein and uses thereof |
11/24/2011 | US20110287004 Mg53 compositions and methods of use |
11/24/2011 | US20110286987 Quenching methods for red blood cell pathogen inactivation |
11/24/2011 | US20110286985 Method of treatment using organotypically cultured skin tissue comprising niks cells that express exogenous hif-1a |
11/24/2011 | US20110286984 Gene encoding human glucokinase mutant, enzyme encoded by the same, recombinant vectors and hosts, pharmaceutical compositions and uses thereof, methods for treating and preventing diseases |
11/24/2011 | US20110286983 Long lasting drug formulations |
11/24/2011 | US20110286982 Glucagon analogues |
11/24/2011 | US20110286981 Glucagon analogues |
11/24/2011 | US20110286980 Methods for inducing selective apoptosis |
11/24/2011 | US20110286978 Genetically Intact Induced Pluripotent Cells Or Transdifferentiated Cells And Methods For The Production Thereof |
11/24/2011 | US20110286977 G6PC2-Encoded Beta Cell Surface Tags |
11/24/2011 | US20110286973 Methods for introducing heterologous cells into fish |
11/24/2011 | US20110286963 Human soluble cd146, preparation and uses thereof |
11/24/2011 | US20110286957 Multiblock copolymers |
11/24/2011 | US20110286934 Membrane transduction peptides, polynucleotides, and methods |
11/24/2011 | CA2800174A1 Antigen specific tregs and related compositions, methods and systems |
11/24/2011 | CA2799988A1 Biomass production |
11/24/2011 | CA2799559A1 Production of dha and other lc-pufas in plants |
11/24/2011 | CA2799050A1 Udp-glucose-4-epimerase useful for improving agronomic performance of plants |
11/24/2011 | CA2798778A1 Anti-human trop-2 antibody having anti-tumor activity in vivo |
11/23/2011 | EP2388332A1 Process for the production of delta5-unsaturated fatty acids in transgenic organisms |
11/23/2011 | EP2388330A1 Liver engrafting cells, assays, and uses thereof |
11/23/2011 | EP2388323A2 Humanized anti-9 integrin antibodies and the uses thereof |
11/23/2011 | EP2388321A1 Novel expression vector |
11/23/2011 | EP2388314A1 Method for controlling proliferation of cord blood hematopoietic stem cells and use thereof |
11/23/2011 | EP2388277A2 Human anti-B7RP1 neutralizing antibodies |
11/23/2011 | EP2388276A2 Human anti-B7RP1 neutralizing antibodies |
11/23/2011 | EP2388275A2 An aglycosylated IgG1 antibody to CD3 |
11/23/2011 | EP2388265A1 Compositions and methods for the treatment of immune related diseases |
11/23/2011 | EP2388022A1 Cell culture and process for preparing the same |
11/23/2011 | EP2388014A1 Therapeutic application of tumoral immunoglobulin variable region peptides in patients with B-cell malignancies |
11/23/2011 | EP2387627A1 Adaptive immunity profiling and methods for generation of monoclonal antibodies |
11/23/2011 | EP2387609A2 Non-embryonic stem cells and uses thereof |
11/23/2011 | EP2377926A9 Chondrocyte-like cell, and method for producing same |
11/23/2011 | EP2247181B1 Method for preserving sperm and applications thereof |
11/23/2011 | EP2061873B1 Cell delivery matrices |
11/23/2011 | EP1663263B1 Use of adipose tissue cells for initiating the formation of a functional vascular network |
11/23/2011 | EP1608683B1 Antibodies directed against hepatitis c virus e1e2 complex and pharmaceutical compositions |
11/23/2011 | EP1509541B1 Novel recombinant anticoagulant proteins |
11/23/2011 | EP1435787B1 Nestin-expressing hair follicle stem cells |
11/23/2011 | EP1362105B1 Anti-interferon-alpha antibodies |
11/23/2011 | EP0932688B1 Chrysosporium cellulase and methods of use |
11/23/2011 | CN1832960B Immunomodulating compositions, uses therefor and processes for their production |
11/23/2011 | CN102257388A Monoclonal antibody stro-4 |
11/23/2011 | CN102257138A Tumor antigen peptide and use thereof |
11/23/2011 | CN102257133A Chondrocyte-like cell, and method for producing same |
11/23/2011 | CN102257132A Methods and compositions for cell attachment and cultivation on planar substrates |
11/23/2011 | CN102257131A Feed supplement for mammalian cell culture and methods of use |
11/23/2011 | CN102257130A Compositions and methods for treating thymic stromal lymphopoietin (tslp)-mediated conditions |
11/23/2011 | CN102257124A Organ-on-a-chip-device |
11/23/2011 | CN102257001A soluble polypeptides for use in treating autoimmune and inflammatory disorders |
11/23/2011 | CN102256606A Methods and means for efficient skipping of at least one of the following exons of the human duchenne muscular dystrophy gene: 43, 46, 50- 53. |
11/23/2011 | CN102251013A Antibody and antigen for recognizing tumor initiator cell and application thereof |
11/23/2011 | CN102250952A Vector for mediating high-efficiency expression of exogenous gene in cells of mammal and use thereof |
11/23/2011 | CN102250928A Delta-6 fatty acid dehydrogenase mutant gene and expression carrier and application thereof |
11/23/2011 | CN102250925A Glutamine synthetase gene, protein coded by same and cloning method therefore |
11/23/2011 | CN102250918A Recombinant human interferon-like proteins |
11/23/2011 | CN102250917A Method for preparing IL28B and special recombinant bacterium |
11/23/2011 | CN102250911A Soluble B7-H1 quantitative detection kit |
11/23/2011 | CN102250910A Human soluble B7-DC quantitative detection kit |
11/23/2011 | CN102250909A Shellfish lectin gene and application thereof |
11/23/2011 | CN102250908A Rice seed 26kD globulin Glb-1 gene terminator and application thereof |
11/23/2011 | CN102250907A Rice glutelin gene GluA-2 terminator and use thereof |
11/23/2011 | CN102250906A Rice seed glutelin GluD-1 gene terminator and application thereof |
11/23/2011 | CN102250905A Rice seed 16kD gliadin gene terminator and application thereof |
11/23/2011 | CN102250904A Medicine for preventing and/or treating melanoma |